Microcytic anemia differential diagnostic;Diagnóstico diferencial de anemias microcíticas

Acta Bioquimica Clinica Latinoamericana

Volumn 38, Issue 4, 2004, Pages 465-469

  Larregina, Alejandra ^a   Reimer, Enrique ^a   Suldrup, Niels ^a   Luis, Sebastián ^a   Zavatti, Jorge ^b   Polini, Nelida Nora ^c  

^a IACA Laboratories   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PATAGONIA SAN JUAN BOSCO   (Argentina)

^c UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

Ferropenia; Microcytic anemia; Thalassemia

Indexed keywords

HEMOGLOBIN A2;

ADULT; ARTICLE; BLOOD SAMPLING; CELLULAR DISTRIBUTION; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ELECTROPHORESIS; ERYTHROCYTE; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROCYTIC ANEMIA; THALASSEMIA;

EID: 18844428851     PISSN: 03252957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. WHO. Iron deficiency anemia. Tech Rep Sem 1959; 182: 4.
2. Vives Corrons JL, Besson I. Los valores de referencia en hematología. Sangre 1992; 38: 63-5.
3. Joan Domingo Saigí. Medicina de Tarragona. La anemia. 2003 http://www.medicadetarragona.es/aula/Laboratorio/la_anemia.htm.
4. Artaza JR, Carbia CD, Ceballo MF, Diaz NB. Indice de distribución de los glóbulos rojos (RDW): su aplicación en la caracterización de anemias microcíticas e hipocrómicas. Medicina 1999; 59: 17-22.
5. Kazazian H, Boehm C. Molecular basis and prenatal diagnosis of β-Thalassemia. Blood 1988; 72: 1107-16.
6. Olivieri N. The β-Thalassemias. N Engl J Med 1999; 341: 99-109.
7. Pierce HI, Kurachi S, Sofroniadou K, Stamatoyannopoulos G. Frequencies of thalassemias in American Blacks. Blood 1977; 49: 981-6.
8. Cao A, Galanello R, Rosatelli MC. Clinical experience of management of thalassemia: the Sardinian experience. Semin Hematol 1996; 33: 66-75.
9. Varela V, Abreu S, Rossetti LC, Targovnik H. Mutaciones beta talasémicas más frecuentes en la población argentina. Sangre 1996; 41 (2): 137-40.
10. Roldán A, Gutiérrez M, Cygler A, Bonduel M, Sciuccati G, Feliú Torres A. Molecular characterization of β-thalassemia genes in an Argentine population. Am J Hematol 1997; 54: 179-82.
11. Benz EJ, Forget BG. Defect in messenger RNA for human hemoglobin synthesis in beta thalassemia. J Clin Invest 1971; 50: 2755-9.
12. Bank A. Genetic defects in the thalassemias. Curr Top Hematol 1985; 5: 1-23.
13. Kazazian HH. The thalassemias syndromes: molecular basics and prenatal diagnosis in 1990. Semin Hematol 1990; 27: 209-28.
14. Siedel J, Wahlefeld AW, Ziegenhorn J. A new iron ferro zine-reagent without deproteinization. Clin Chem 1984; 30: 975-9.
15. Huisman THJ, Schoroeder WA, Brodie AN. Microchromatography of hemoglobins. A simplified method for the determination of hemoglobin A2. J Lab Clin Med 1975; 86: 700-6.
16. Saiki RK, Chank CA, Lenvenson CH, Warren TC, Boehm CD, Kazazian HH et al. Diagnosis of sickle cell anemia and β thalassemia with enzymatically amplified DNA and non radioactive allele- specific oligonucleotide probes. N Engl J Med 1988; 319: 537-41.
17. Siegel S, John Castellan N. Estadística no paramétrica. Editorial Trillas SA de CV. México. 1995; ISBN 968-24-5101-9.
18. Freund R, Wilson W. Statistical Methods. Academic Press. San Diego. 1997. ISBN 0-12-267472-3.
19. De Maeyer EM. Preventing and controlling Iron Deficiency anaemia througth primary health care. A guide for health administrators and programme managers. Geneve. World Health Organization 1989.
20. Aixalá MTF. Prevalencia y perfil hematimétrico de β talasemia menor. Hematología 2003; 7: 183-6.
21. Oliva Berini E, Caladera A, Torrent M. Campaña para la detección de beta talasemia menor y prevención de la mayor en la isla de Mallorca. Experiencia de 10 años. Med Clin 1998; 110: 361-4.
22. Thein SL, Wainscoat JS, Old JM, Sampietro M, Fiorelli G, Wallace RB, et al. Feasibily of β-thalassemia with synthetic DNA probes in two Mediterranean populations. Lancet 1985; 2: 345-7.